Anticoagulants
This is the therapeutic use of anticoagulants
Inhibit clot formation and prevent venous thrombosis
Over the counter antiplatelet drug used for thromboembolism prophylaxis
Aspirin
The peak action time of the thrombolytic drug Alteplase
5-10 minutes
Patient teaching needed for patient on warfarin
Monitor for s/s of bleeding
Have INR test routinely as recommended by provider
Don't take NSAIDs
Use electric razor
Use soft toothbrush to prevent bleeding gums
Alteplase
Thrombolytic drug
Used for its rapid anticoagulant effect of thrombosis
Heparin
Daily Double
This is the therapeutic use of antiplatelet drugs
Prevents arterial thrombosis
Time frame in which to administer a thrombolytic drug after a thrombotic stroke
Within 3 hours
Patient goal for patient on anticoagulant
Patient will not have excessive bleeding
Heparin and warfarin
Anticoagulant
This drug is a LMWH
Enoxaparin or dalteparin
Antiplatelet drug used after MI or stroke to prevent a second event
Clopidogrel
Therapeutic use of thrombolytic drugs
Disintegrates blood clots
Nursing concept associated with anticoagulant drug use
Clotting
Clopidogrel
Antiplatelet
Antagonist drug that reverses the action of heparin
Protamine sulfate
Antiplatelet drug used primarily to treat claudication and PVD
Cilostazol
Duration of action of Alteplase
1 hour
Daily Double
Diet recommendation in patient teaching for patient on warfarin
Avoid or limit green, leafy vegetables due to high vitamin K content and alcohol
Cilostazol
Antiplatelet
Lab test used to regulate the dose of warfarin
International normalized ratio (INR)
Recommended aspirin dose range for patients with a family history of stroke or MI
50-325 mg/day
Mechanism of action of the thrombolytic drug Alteplase
Promotes conversion of plasminogen to plasmin and initiates fibrinolysis
Nursing intervention anticipated for patient on warfarin with uncontrollable bleeding
Vitamin K
Enoxaparin
LMWH anticoagulant